Miss Chloe Constantinou
Breast Surgeon
Special Interest
Surgery for Breast CancerImmediate Breast ReconstructionRisk Reducing SurgeryOncoplastic TechniquesTherapeutic Breast ReductionBreast Conservation Surgery for Large Breast TumoursBreast Volume Replacement Techniques for Cancer
Language Spoken
English, Greek
Accreditations
MD, PhD
Biography
Miss Chloe Constantinou is a Specialist Oncoplastic Breast Surgeon. She is currently Consultant Breast Surgeon at Kingston Hospital NHS Foundation Trust, and an Honorary Consultant Breast Surgeon at The Royal Marsden Hospital.
She obtained higher general surgical training in Red Cross Hospital in one of the busiest and largest hospitals in Athens. She received further training in breast surgery and advanced oncoplastic breast surgery techniques at some of London's world’s famous Breast Units including Imperial College London and Royal Free Hospital.
Prior to taking up a Consultant Oncoplastic Breast Surgeon post at Kingston NHS Foundation Hospital she undertook a prestigious Oncoplastic Fellowship in Breast Surgery at Royal Marsden Hospital, London. Academically in 2018, she was awarded a PhD thesis for her research on Triple Negative Breast Cancer, at University of Ioannina, School of Medicine, Greece; a retroprospective project that investigated the correlation of immnunohistochemical markers with the prognosis of triple negative breast cancer. The results were published in peer review journals.
She has an active interest in surgical research and has published widely in peer reviewed journals. Her special interests include surgery for breast cancer, immediate breast reconstruction, risk reducing surgery, oncoplastic techniques, therapeutic breast reduction, breast conservation surgery for large breast tumours, and breast volume replacement techniques for cancer.
She runs rapid diagnostic clinics and patients that undergoing a biopsy are discussed in the Multi-Disciplinary Team, of breast surgeons, radiologists, oncologists, histopathologists and specialist nurses who meet on a weekly basis to discuss patient cases with the aim to provide best quality of care.
Key Publications
- Expression and Clinical Significance of claudin-7, PDL-1, PTEN, c-Kit, c-Met, cMyc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple Negative Breast Cancer.
A Single Centre Prospective Observational Study. C Constantinou, S Papadopoulos, E Karyda, A Alexopoulos, N Agnanti, A Batistatou and H Harisis, in vivo32: 303-311 (2018) doi:10.21873/invivo.11238
Inflammation and breast cancer. C Constantinou, IS Fentiman.
Breast Cancer Management, 2013 Vol. 2, No. 4, Pages 311-325, DOI 10.2217/bmt.13.26 (doi:10.2217/bmt.13.26)
Ductal Carcinoma in Situ Treatment Requires a Multidisciplinary Approach. C Constantinou, IS Fentiman. Journal of Cancer Therapy 2013. Vol. 4 No. 7, Article ID: 36240 , 14 pages DOI:10.4236/jct.2013.47140
The value of plasma neurotensin and cytokine measurement for the detection of bowel ischaemia in clinically doubtful cases: a prospective study. Sgourakis G, Papapanagiotou A, Kontovounisios C, Karamouzis MV, Lanitis S, Konstantinou C, Karaliotas C, Papavassiliou AG.Exp Biol Med (Maywood).
Diagnosis and treatment of Male Breast Cancer. Chloe Constantinou and Ian Fentiman. Breast cancer Management, 2013 Vol. 1, No. 4, Pages 295-304 , DOI. 10.2217/bmt.12.47 (doi:10.2217/bmt.12.47
